CareFusion News

The firm currently has a $30.00 price target on the stock. A number of other analysts have also recently weighed in on CFN.

CareFusion receives an FDA warning letter regarding a manufacturing site in Mexico where it found violations and that a company follow up dated February 13 was not adequate.

May 21 - Wells Fargo's Ann Miletti says to look for companies trading at least 20% below their ''private market value'' and likes chipmaker ON Semiconductor and healthcare co.

Gallahue, an AdvaMed board chairman, sent an email to U.S.-based CareFusion employees to consider signing the online petition which launched on April 17, 2012.

CFN has been the subject of a number of other recent research reports. Analysts at Raymond James initiated coverage on shares of CareFusion in a research note to investors on Wednesday, April 25th.

Shares of Synergy Pharmaceuticals go into the abyss, following the pharma's announcement that it intends to offer 10 million common stock shares to finance its research and development activities, which include clinical trials of its plecanatide and SP-333 treatments for gastrointestinal disorders.

On Thursday, CareFusion Corp reported its third quarter earnings and discussed the following topics in its earnings conference call.